| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.66▼ | 1.71▼ | 1.71▼ | 1.72▼ | 1.44▲ |
| MA10 | 1.72▼ | 1.79▼ | 1.80▼ | 1.41▲ | 1.55▲ |
| MA20 | 1.77▼ | 1.84▼ | 1.82▼ | 1.42▲ | 1.97▼ |
| MA50 | 1.85▼ | 1.76▼ | 1.51▲ | 1.52▲ | N/A |
| MA100 | 1.81▼ | 1.51▲ | 1.58▲ | 2.06▼ | N/A |
| MA200 | 1.58▲ | 1.79▼ | 1.82▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.019▼ | -0.038▼ | -0.048▼ | 0.075▲ | N/A |
| RSI | 38.050▼ | 41.273▼ | 45.733▼ | 51.617▲ | 44.329▼ |
| STOCH | 12.275▼ | 22.026 | 25.575 | 71.363 | 24.518 |
| WILL %R | -94.595▼ | -95.238▼ | -95.506▼ | -38.790 | -74.700 |
| CCI | -85.468 | -128.388▼ | -109.358▼ | 91.721 | -12.070 |
|
Thursday, April 25, 2024 01:10 PM
NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic, and CAR-NK NK cell therapeutics. NKGen is headquartered in Santa ...
|
|
Wednesday, April 24, 2024 01:45 PM
SANTA ANA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative ...
|
|
Tuesday, April 23, 2024 09:00 AM
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/04/24 | 1.90 | 1.95 | 1.60 | 1.61 | 546,549 |
| 25/04/24 | 1.65 | 2.11 | 1.65 | 1.98 | 2,068,292 |
| 24/04/24 | 1.71 | 1.96 | 1.61 | 1.71 | 1,461,400 |
| 23/04/24 | 1.62 | 1.95 | 1.52 | 1.85 | 11,523,468 |
| 22/04/24 | 1.31 | 1.72 | 1.20 | 1.47 | 23,765,525 |
| 19/04/24 | 0.8342 | 1.62 | 0.8342 | 1.106 | 4,923,221 |
| 18/04/24 | 1.00 | 1.02 | 0.821 | 0.86 | 350,135 |
| 17/04/24 | 1.11 | 1.13 | 1.02 | 1.03 | 183,582 |
| 16/04/24 | 1.25 | 1.25 | 1.20 | 1.21 | 53,597 |
| 15/04/24 | 1.21 | 1.27 | 1.20 | 1.24 | 85,812 |
|
|
||||
|
|
||||
|
|